In accordance with the Ministry of Food and Drug Safety's 'Drug Approval Change Order' (Drug Management Division-No. 11377, effective date December 22, 2014), the dosage and precautions for use of Linac Injection have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Linac Inj.
Attachments are original documents and may be in Korean. English editions are labeled separately.
Linakju Usage Dosage_Precautions for Use_1.hwpLinakju Usage Dosage_Precautions for Use_1.hwp · 29 KBDownload ↓